(Alliance News) - Indivior PLC on Thursday said it has promoted the former chief financial officer of fellow pharmaceutical firm Shire PLC to chair with immediate effect.
Graham Hetherington joined the Indivior board as a non-executive director in November of last year. He replaces Daniel Tasse, who steps down as interim chair but remains senior independent director. Tasse stepped into the role in September when Howard Pien, who had been on a medical leave since mid-June, resigned.
Hetherington was CFO of Shire from 2008 until 2014. The Irish company was acquired by Japan's Takeda Pharmaceutical Co Ltd at the end of 2018. Prior to Shire, Hetherington was CFO of rum-maker Bacardi & Co and of drinks firm Allied Domecq PLC.
Hetherington said: "Indivior is at an important stage of its development. I am honoured to be appointed chair of the board at this time. Indivior is a pioneer in its field, and I look forward to working with the board and leadership team to realise sublocade's (buprenorphine extended-release) full potential and more broadly its important Vision on behalf of all stakeholders."
Sublocade is one of Indivior's opioid dependence treatments.
Indivior said it plans to search for an additional independent non-executive director.
Shares in Indivior were up 1.0% at 131.00 pence in London on Thursday.
By Zoe Wickens; zoewickens@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Indivior (INDV)